Emerging peptide therapeutics for the treatment of ovarian cancer
Expert Opin Emerg Drugs. 2023 Jun 7:1-16. doi: 10.1080/14728214.2023.2218643. Online ahead of print.ABSTRACTINTRODUCTION: The discovery of therapeutic proteomic targets has resulted in remarkable advances in oncology. Identification of functional and hallmark peptides in ovarian cancer can be leveraged for diagnostic and therapeutic targeting. These targets are expressed in different tumor cell locations, making them excellent candidates for theranostic imaging, precision therapeutics, and immunotherapy. The ideal target is homogeneously overexpressed in malignant cells with no expression in healthy cells, thereby avoiding...
Source: Expert Opinion on Emerging Drugs - June 7, 2023 Category: Drugs & Pharmacology Authors: Ana C Veneziani Eduardo Gonzalez-Ochoa Amit M Oza Source Type: research